Citations

Citations to this article as recorded by  

• Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
  Sisi Zhou, Zeyu Huang, Wenjing Hou, Yiting Lin, Jing Yu
  Inflammation Research.2024; 73(2): 199.     CrossRef
• Role of diet in prevention versus treatment of Crohn’s disease and ulcerative colitis
  Emma P Halmos, Lihi Godny, Julie Vanderstappen, Chen Sarbagili-Shabat, Vaios Svolos
  Frontline Gastroenterology.2024; : flgastro-2023-102417.     CrossRef
• Immunoregulatory Effects of Elemental Diet and Its Ingredient, Tryptophan, via Activation of the Aryl Hydrocarbon Receptor in Mice
  Atsuhito Kubota, Shungo Imai, Ryoichi Aoyagi, Wataru Murase, Masaru Terasaki, Mitsuru Sugawara, Yoh Takekuma, Hiroyuki Kojima
  International Journal of Molecular Sciences.2024; 25(6): 3448.     CrossRef
• Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study
  Wei Wang, Anning Yin, Jing Wang, Jiao Li, Jingyun Cheng, Jian Kang, Yaqing Xu, Yueyue Lu, Yuanping Yang, Juan Su, Qian Zhou, Ya Liu, Zhishun Tang, Haixia Ren, Weiwei Li, Weiguo Dong, Baoping Yu, Ping An
  Clinical Nutrition.2024; 43(6): 1291.     CrossRef
• "Out of the box� new therapeutic strategies for Crohn�s disease: moving beyond biologics
  Ignacio Catalán-Serra, Pret Ricanek, Tore Grimstad
  Revista Española de Enfermedades Digestivas.2022;[Epub]     CrossRef
• Nutritional Therapy Strategies in Pediatric Crohn’s Disease
  Charlotte M. Verburgt, Mohammed Ghiboub, Marc A. Benninga, Wouter J. de Jonge, Johan E. Van Limbergen
  Nutrients.2021; 13(1): 212.     CrossRef
• Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
  Hiroshi Nakase, Motoi Uchino, Shinichiro Shinzaki, Minoru Matsuura, Katsuyoshi Matsuoka, Taku Kobayashi, Masayuki Saruta, Fumihito Hirai, Keisuke Hata, Sakiko Hiraoka, Motohiro Esaki, Ken Sugimoto, Toshimitsu Fuji, Kenji Watanabe, Shiro Nakamura, Nagamu I
  Journal of Gastroenterology.2021; 56(6): 489.     CrossRef
• Diet and nutrition in the management of inflammatory bowel disease
  Pabitra Sahu, Saurabh Kedia, Vineet Ahuja, Rakesh K. Tandon
  Indian Journal of Gastroenterology.2021; 40(3): 253.     CrossRef
• Nutritional Aspects of Pediatric Gastrointestinal Diseases
  Teresa Di Chio, Christiane Sokollik, Diego G. Peroni, Lara Hart, Giacomo Simonetti, Franziska Righini-Grunder, Osvaldo Borrelli
  Nutrients.2021; 13(6): 2109.     CrossRef
• Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
  Sanchit Sharma, Arti Gupta, Saurabh Kedia, Samagra Agarwal, Namrata Singh, Sandeep Goyal, Saransh Jain, Vipin Gupta, Pabitra Sahu, Sudheer Kumar Vuyyuru, Bhaskar Kante, Raju Sharma, Rajesh Panwar, Peush Sahni, Govind Makharia, Vineet Ahuja
  Intestinal Research.2021; 19(3): 291.     CrossRef
• Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease
  Lara Hart, Charlotte M. Verburgt, Eytan Wine, Mary Zachos, Alisha Poppen, Mallory Chavannes, Johan Van Limbergen, Nikhil Pai
  Nutrients.2021; 14(1): 4.     CrossRef
• Efficacy of enteral nutrition in patients with Crohn’s disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis
  Fumihito Hirai, Teruyuki Takeda, Yasumichi Takada, Masahiro Kishi, Tsuyoshi Beppu, Noritaka Takatsu, Masaki Miyaoka, Takashi Hisabe, Kenshi Yao, Tosiharu Ueki
  Journal of Gastroenterology.2020; 55(2): 133.     CrossRef
• Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns?-
  Shinji Okabayashi, Taku Kobayashi, Toshifumi Hibi
  Journal of the Anus, Rectum and Colon.2020; 4(1): 1.     CrossRef
• Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience
  Ajit Sood, Arshdeep Singh, Ritu Sudhakar, Vandana Midha, Ramit Mahajan, Varun Mehta, Yogesh Kumar Gupta, Kirandeep Kaur
  Intestinal Research.2020; 18(2): 184.     CrossRef
• Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow
  Tadakazu Hisamatsu
  Intestinal Research.2020; 18(2): 139.     CrossRef
• Half-Elemental Diet Shifts the Human Intestinal Bacterial Compositions and Metabolites: A Pilot Study with Healthy Individuals
  Jun Miyoshi, Daisuke Saito, Mio Nakamura, Miki Miura, Tatsuya Mitsui, Toru Kudo, Shinnosuke Murakami, Minoru Matsuura, Tadakazu Hisamatsu
  Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
• Fool me once… treatment exposure to achieve remission in pediatric IBD
  Johan E. Van Limbergen, Bart G. P. Koot, J. Peter de Winter
  European Journal of Pediatrics.2020; 179(12): 1921.     CrossRef
• Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease
  Esteban Sáez-González, Beatriz Mateos, Pedro López-Muñoz, Marisa Iborra, Inés Moret, Pilar Nos, Belén Beltrán
  Nutrients.2019; 11(5): 1062.     CrossRef

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing prevalence worldwide. IBD Ahead is an international educational program that aims to explore questions commonly raised by clinicians about various areas of IBD care and to consolidate available published evidence and expert opinion into a consensus for the optimization of IBD management. Given differences in the epidemiology, clinical and genetic characteristics, management, and prognosis of IBD between patients in Japan and the rest of the world, this statement was formulated as the result of literature reviews and discussions among Japanese experts as part of the IBD Ahead program to consolidate statements of factors for disease prognosis in IBD. Evidence levels were assigned to summary statements in the following categories: disease progression in CD and UC; surgery, hospitalization, intestinal failure, and permanent stoma in CD; acute severe UC; colectomy in UC; and colorectal carcinoma and dysplasia in IBD. The goal is that this statement can aid in the optimization of the treatment strategy for Japanese patients with IBD and help identify high-risk patients that require early intervention, to provide a better long-term prognosis in these patients.

Citations

Citations to this article as recorded by  

• Precision medicine in inflammatory bowel diseases
  Ashwin N. Ananthakrishnan
  Intestinal Research.2024; 22(1): 8.     CrossRef
• A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
  Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
  Annals of Pharmacotherapy.2023; 57(9): 1053.     CrossRef
• Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis
  Kunio Asonuma, Taku Kobayashi, Masaru Nakano, Shintaro Sagami, Hiroki Kiyohara, Mao Matsubayashi, Hiromu Morikubo, Yusuke Miyatani, Shinji Okabayashi, Hajime Yamazaki, Yuichiro Kuroki, Toshifumi Hibi
  Inflammatory Bowel Diseases.2022; 28(2): 200.     CrossRef
• Intestinal cancer in patients with Crohn's disease: A systematic review and meta‐analysis
  Motoi Uchino, Hiroki Ikeuchi, Keisuke Hata, Tomohiro Minagawa, Yuki Horio, Ryuichi Kuwahara, Shiro Nakamura, Kenji Watanabe, Masayuki Saruta, Toshimitsu Fujii, Taku Kobayashi, Ken Sugimoto, Fumihito Hirai, Motohiro Esaki, Sakiko Hiraoka, Katsuyoshi Matsuo
  Journal of Gastroenterology and Hepatology.2021; 36(2): 329.     CrossRef
• MR-enterography in Crohn’s disease: what MRE mural parameters are associated to one-year therapeutic management outcome?
  Pier Paolo Mainenti, Fabiana Castiglione, Antonio Rispo, Ettore Laccetti, Salvatore Guarino, Valeria Romeo, Anna Testa, Leonardo Pace, Simone Maurea
  The British Journal of Radiology.2021;[Epub]     CrossRef
• Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn’s Disease: A Nationwide Population-Based Study
  Eun Mi Song, Ho-Su Lee, Ye-Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu, Suk-Kyun Yang
  Digestive Diseases and Sciences.2020; 65(4): 1189.     CrossRef
• Passion fruit (Passiflora edulis) leaf aqueous extract ameliorates intestinal epithelial barrier dysfunction and reverts inflammatory parameters in Caco-2 cells monolayer
  Mônica Cristina Lopes do Carmo, Isabela Mateus Martins, Ana Elisa Ramos Magalhães, Mário Roberto Maróstica Júnior, Juliana Alves Macedo
  Food Research International.2020; 133: 109162.     CrossRef
• Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
  Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki
  Intestinal Research.2019; 17(3): 375.     CrossRef